Skip to main content
DNLI logo

DNLI · Denali Therapeutics Inc.

Track DNLI — free
$24.02 -0.91 (-3.63%)
Market Cap
$3.98B
Shares
159.85M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 293
Total Value: $4,043,035,962
Total Shares: 157,254,065

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 293 13F filers · Δ vs Mar 31, 2026
Top Holder
10.3%
Sep 2023 → Jun 2026 · range 8.8% – 13.5%
+1.5 pts
Top 5
35.8%
Sep 2023 → Jun 2026 · range 31.6% – 46.2%
+4.1 pts
Top 10
51.9%
Sep 2023 → Jun 2026 · range 49.0% – 65.1%
+3.0 pts
HHI
397
Sep 2023 → Jun 2026 · range 340 – 560
Broadly held+57

Quarterly Activity

vs Mar 31, 2026
New
54
Increased
123
Decreased
67
Sold Out
33
Unchanged
49
Holder count: +21
Institutional value: +42.0%
Shares held: +6.1%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 298
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1714899 CUSIP 24823R105 13F (30d) 262 filings 255 filers Visit website Investor relations